Consensus SK bioscience Co.,Ltd.

Equities

A302440

KR7302440003

End-of-day quote Korea S.E. Other stock markets 06:00:00 2024-05-16 pm EDT			5-day change	1st Jan Change
59,500 ^KRW	-1.00%		-0.67%	-17.36%

May. 03	SK Bioscience's Attributable Loss Narrows in Q1	MT
Mar. 28	SK Bioscience Signs Deal with Sanofi for Five Vaccine Types	MT

Evolution of the average Target Price on SK bioscience Co.,Ltd.

Price target over the last 5 years

History of analyst recommendation changes

18512ee45e89cb1a2a1.UufvzMRhKA-A-cZMH2copevUexEzl_DBnXW8V3djx90.FbKooLUHZUTfvaU5fR8Z3Zu7Pyhk26-C_D3YIygw9-Url5mfqjEdN-OOqQ~af4484ec97be7f7acba1384f64cb5384

Analyst Recommendations on SK bioscience Co.,Ltd.

South Korean Stocks Close Flat After Fed Rate Hike; SK Bioscience Rises 16%	23-05-04	MT
S.Korean stocks, won drop on Fed rate-hike bets, China slowdown fears	22-04-25	RE
South Korea’s Kospi Declines 1% on Russia-Ukraine Conflict, Possible US Fed Rate Hikes; SK Bioscience Plunges 10%	22-02-15	MT

More recommendations

Analysts' Consensus

Sell

Buy

Mean consensus

UNDERPERFORM

Number of Analysts

Last Close Price

59,500 KRW

Average target price

58,000 KRW

Spread / Average Target

-2.52%

High Price Target

89,000 KRW

Spread / Highest target

+49.58%

Low Price Target

35,000 KRW

Spread / Lowest Target

-41.18%

Consensus detail

Consensus revision (last 18 months)

Ratings for SK bioscience Co.,Ltd.

Trading Rating

Investor Rating

ESG Refinitiv

B-

More Ratings

EPS Revisions

Estimates Revisions

Quarterly revenue - Rate of surprise

Company calendar